Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
6 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

    • Preclinical Development
    • Pharmacology
    • Oncology
    • Pharma Policy
    • Pharma Regulation
    • Biomedical R&D
    • Pharmaceutical R&D
    • Translational Science and Biomarkers
    • Precision Medicine
    • Drug Discovery
    • Safety & Toxicology
    • biomarkers
    • patient stratification
    • Personalised Healthcare
    • Translational & Pre-clinical Research
    • Translational & Surgical Biology
    • pharma R&D
    • Small Molecules
    • Advanced Therapies
    • Oncology & Radiotherapeutics
    • Specialised Indications
    • The Discovery Loop

    Optimising Preclinical Pharmacology for Oncology NMEs

    • Longevity
    • Tech and Innovation
    • Translational Science and Biomarkers
    • Patient Enrolment
    • Artificial Intelligence in Healthcare
    • Deep Longevity
    • patient stratification
    • Biotech
    • biomarkers
    • clinical trials
    • Biomedical R&D
    • Medtech
    • Translational & Pre-clinical Research
    • AI & Advanced Healthcare
    • AI & Machine Learning
    • AI Drug Discovery
    • Genetics & Molecular Biology
    • Precision Medicine
    • Personalised Healthcare
    • Healthcare Technology
    • Digital Health
    • Data and Digital Health
    • ageing clocks
    • Biological Ageing
    • biological age
    • Diagnostics

    Could Biological Age Become Pharma's Most Important Biomarker?

    • Preclinical Development
    • Drug Discovery
    • AI Drug Discovery
    • Pharma Policy
    • Pharma Regulation
    • Safety & Toxicology
    • Global Regulatory Affairs
    • Drug Approval
    • Biomedical R&D
    • Pharmaceutical R&D
    • Translational & Pre-clinical Research
    • Pharmacology
    • Regulatory & IP
    • Pharmaceutical Compliance
    • The Discovery Loop

    FDA 2026 Draft Guidance on Alternatives to Animal Testing